NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...

The Food and Drug Administration authorized Novavax's updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and ...

(Reuters) - Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, on Wednesday said it would be challenging to distribute vaccines that use messenger RNA based ...

Vaccines have been in the news lately, and not because of their lifesaving potential. Some US parents have grown hesitant about vaccinating their children. And the vaccine skepticism expressed by ...

PHILADELPHIA (WPVI) -- A local researcher from Penn Medicine says there's reason to believe at least one other potential coronavirus vaccine could be as effective as Pfizer's vaccine is said to be.

(NewsNation) — President Donald Trump’s new “Make America Healthy Again” commission is reviewing certain vaccines and ...

The Trump administration on Tuesday eliminated 22 mRNA vaccine development projects for COVID-19 and bird flu, a stark shift away from technology credited with bringing the United States out of the ...

The Food and Drug Administration authorized Novavax's new protein-based Covid vaccine for emergency use in people ages 12 and up. Novavax's vaccine targets the highly contagious omicron subvariant ...

Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, on Wednesday said it would be challenging to distribute vaccines that use messenger RNA based technology in ...

Novavax's vaccine targets the highly contagious omicron subvariant JN.1, which began circulating widely in the U.S. earlier this year. JN.1 only accounted for 0.2% of cases circulating nationwide as ...